OXFORD BIOMEDICA IS GRANTED KEY PATENTS IN CHINA

These are the first patents covering the commercial use of the Company's LentiVector technology in China, the only country in the world with an approved gene therapy product and a country where opportunities for innovative pharmaceutical development is widely predicted to grow substantially over the next decade.

Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=27218&nfid=mnf)